Clinical Trials
3
Active:1
Completed:2
Trial Phases
2 Phases
Phase 3:1
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (50.0%)Phase 4
1 (50.0%)Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms
Phase 4
Completed
- Conditions
- Lower Urinary Tract SymptomsOveractive BladderBenign Prostatic Hyperplasia (BPH)
- Interventions
- First Posted Date
- 2016-03-22
- Last Posted Date
- 2016-03-22
- Lead Sponsor
- Astellas Pharma Taiwan, Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT02715024
- Locations
- 🇨🇳
Site, Taipei, Taiwan
A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout
- First Posted Date
- 2012-11-29
- Last Posted Date
- 2014-10-29
- Lead Sponsor
- Astellas Pharma Taiwan, Inc.
- Target Recruit Count
- 109
- Registration Number
- NCT01736514
News
No news found